# Assessment of SARS-CoV-2 Seroprevalence in Detention

> **NCT04516512** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1044 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Blood draw

## Key facts

- **NCT ID:** NCT04516512
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-14
- **Primary completion:** 2021-07-08
- **Final completion:** 2021-07-08
- **Target enrollment:** 1044 (ACTUAL)
- **Last updated:** 2021-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516512, "Assessment of SARS-CoV-2 Seroprevalence in Detention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04516512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*